The results of the research supported by the RakFond by Bulatov E.R.

Immunotherapy with genetically modified lymphocytes, such as CAR-T cells, is one of the most promising areas of modern basic and clinical oncology. A CAR-T cell is ... далее...

HOW TO INITIATE YOUR OWN CLINICAL STUDY

This year, a joint workshop by RUSSCO and RakFond within the XXIII Russian Oncology Congress was dedicated to conducting clinical trials in oncology. Leading experts shared their experiences and discussed examples of what is needed to initiate your own clinical study. далее...

PRESENTATION OF THE STUDY SUPPORTED BY RAKFOND AT 2019 ASCO ANNUAL MEETING

Final results of the randomized phase II trial of olanzapine versus aprepitant in patients receiving high-emetogenic chemotherapy were presented by its author Dr. Alexey Rumyantsev at the Annual Meeting of the American Society of Clinical Oncology (ASCO) during the Symptoms and Survivorship session on June 3, 2019, in Chicago, USA... далее...

WHAT IS CLINICAL RESEARCH

RakFond's SAB Member Professor Nikolay Zhukov, MD, DSci, explains in this video what clinical research is, he describes different types of clinical studies, what they provide to medical doctors, and why taking part in clinical trials is important for patients... далее...

NEWS OF THE 2019 ASCO ANNUAL MEETING: PART I

The American Society of Clinical Oncology (ASCO) Annual Meeting took place at the beginning of June in Chicago, USA. Alexey Rumyantsev, MD in the Department of Clinical Pharmacology and Chemotherapy of the N.N. Blokhin National Medical Research Center of Oncology, RakFond’s grantee, IDEA (International Development and Education Award) awardee and this year’s presenter at the ASCO meeting, has put together the main news of the meeting... далее...

American Society of Clinical Oncology (ASCO) Issues the 14th Annual Report on Progress Against Cancer

ASCO’s Clinical Cancer Advances 2019 highlights the most significant clinical research advances of the past year and identifies priority areas where research efforts should be focused to accelerate progress against cancer... далее...

MOTIVATION AND ROLE OF CLINICAL TRIALS FOR AN ONCOLOGIST’S SUCCESSFUL CLINICAL PRACTICE

By Timur Mitin, MD, PhD, Associate Professor of Radiation Medicine at Oregon Health and Science University, Medical Director of the Tuality/OHSU Cancer Center (Portland, USA). далее...

Cancer statistics: incidence and mortality

This September the International Agency for Research on Cancer (IARC) issued the 2018 update of the GLOBOCAN – the online tool which contains data on incidence and mortality for 36 cancers in 185 countries... далее...